98%
921
2 minutes
20
The application of conventional lateral flow immunoassay (LFIA) remains challenging due to its single signal readout and poor sensitivity. In this work, we developed J-aggregated fluorescence nanoparticles (JNPs) with multichromatic performance and employed them as reporters for the simultaneous and sensitive detection of T-2 and AFB1 toxins on the LFIA platform. Upon the strong confinement effect of nanoparticles, the emission region of JNPs was red-shifted from ∼545 to ∼620 nm, exhibiting a strong J-aggregation phenomenon. Subsequently, two JNPs with green emission and red emission were employed for the development of multiplexed LFIA platform (JNPs-LFIA) for on-site quantitative detection of T-2 and AFB1 toxins, with the limits of detection of 0.645 ng mL and 0.0035 ng mL, which were 3.5-fold and 12.2-fold lower than those of AuNPs-LFIA, respectively. Overall, this work provides an efficient strategy for the design of multichromatic immunoprobes and promotes the development of reporters in biosensing application.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.nanolett.5c01012 | DOI Listing |
Mikrochim Acta
September 2025
Department of Surgical Oncology, Shaanxi Provincial People's Hospital, 256 Friendship West Road, Beilin District, Xi'an, 710068, Shaanxi, China.
Mycoplasma pneumonia, a primary aetiological agent of atypical pneumonia, necessitates the implementation of rapid point-of-care diagnostics. Lateral flow immunoassays (LFIAs) hold promise for point-of-care testing (POCT), yet their sensitivity levels are frequently constrained by probe affinity and matrix interference. We introduce an orientational labelling strategy that employs magnetic nanoparticles (MNPs) functionalized with staphylococcal protein A (SPA) to simultaneously enhance antibody orientation and facilitate magnetic enrichment.
View Article and Find Full Text PDFAnal Chem
September 2025
State Key Laboratory of Food Science and Resources, Nanchang University, Nanchang330047, China.
The photothermal lateral flow immunoassay (LFIA) has garnered considerable attention, owing to its suitability for on-site quantitative detection. Furthermore, it has distinct advantages in further constructing sensitive detection methods for low-concentration targets. In this study, we employed a ligand engineering strategy to synthesize Fe-chelated quinone nanoparticles (FQNPs).
View Article and Find Full Text PDFAnal Chim Acta
October 2025
Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, USA; Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA; Department of Chemistry, Duke University, Durham, NC, 27708, USA. Electronic address:
The lateral flow immunoassay (LFIA) has become a widely accepted point-of-care diagnostic tool (POCT) due to its simplicity, portability, cost-effectiveness, and rapid biomarker detection capabilities. However, its sensitivity in detecting target analytes has been limited by the visual signals produced by traditional gold nanoparticles. In this study, we introduce a highly sensitive near infrared (NIR) photothermal platform using gold nanostars (GNS) with a tunable plasmon resonance band spanning wavelengths from 700 to 850 nm.
View Article and Find Full Text PDFTalanta
August 2025
State Key Laboratory of Chemical Safety, College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao, 266580, China. Electronic address:
The global surge of mpox virus (MPXV) demands diagnostic tools that combine laboratory-grade accuracy with point-of-care simplicity. Here, we report an all-in-one lateral flow immunoassay (LFIA) leveraging precision-engineered FeO-Au heterodimers for dual-signal MPXV quantification via naked-eye readout and photothermal amplification. These monodisperse plasmonic-magnetic nanoparticles, synthesized through controlled seed-mediated heterodimerization, integrate magnetic enrichment, photothermal conversion, and tunable plasmonic resonance into a single architecture.
View Article and Find Full Text PDFAnal Chem
August 2025
State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Conventional lateral flow immunoassays (LFIAs) suffer from limited sensitivity in detecting low-abundance tumor biomarkers, primarily attributed to inefficient antibody utilization and insufficient signal intensity of nano-immunoprobes. Here, we propose a dual-enhanced LFIA integrating oriented antibody anchoring and nanozyme catalytic amplification for ultrasensitive visual detection of tumor biomarkers, denoted as DEOAN-LFIA. Bimetallic catalyst gold-platinum nanoparticles (Au@Pt NPs) were functionalized with phenylboronic acid to selectively orient antibodies via fragment crystallizable (Fc) glycans for improving antibody utilization efficiency, thereby enriching target-probe complexes on the test line (T line), realizing the first-step signal amplification.
View Article and Find Full Text PDF